Want to see HCA full AI Analyst Report?
HCA Stock Chart & Stats
$382.19
$5.69(1.51%)
At close: 4:00 PM EDT
$382.19
$5.69(1.51%)
Day’s Range― - ―
52-Week Range$339.82 - $556.52
Previous CloseN/A
Volume2.70M
Average Volume (3M)1.63M
Market Cap
$84.78B
Enterprise Value$140.85K
Total Cash (Recent Filing)$1.01B
Total Debt (Recent Filing)$48.78B
Price to Earnings (P/E)12.8
Beta0.32
Next Earnings
Oct 23, 2026EPS Estimate
6.78Next Dividend Ex-DateN/A
Dividend Yield0.77%
Share Statistics
EPS (TTM)29.96
Shares Outstanding221,839,800
10 Day Avg. Volume2,010,040
30 Day Avg. Volume1,634,412
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)-17.87
Price to Sales (P/S)1.42
P/FCF Ratio14.00
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$450.17Price Target Upside17.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)29.62
Revenue Forecast (FY)$78.51B
Bulls Say, Bears Say
Bulls Say
Scale & ProfitabilityHCA's large scale and above-average hospital margins provide durable earnings power and bargaining leverage with payers and suppliers. Sustained revenue base across inpatient, outpatient and ER services supports stable cash generation and resilience versus smaller competitors over months.
Cash GenerationStrong operating cash flow and multi-billion dollar FCF give HCA financial resources to fund capex, outpatient expansion, buybacks and interest payments. Consistent cash conversion underpins strategic investments and liability management despite recent FCF weakening.
Network & Outpatient ExpansionOngoing site growth and outpatient pipeline shift care to lower-cost, higher-throughput settings—a structural trend that broadens service reach, improves utilization and supports long-term revenue diversification away from inpatient dependence, enhancing margin potential over several quarters.
Bears Say
High LeverageElevated debt and negative equity materially constrain financial flexibility, increasing refinancing and interest-rate sensitivity. With limited capital cushion, HCA faces higher downside risk from sustained cash-flow weakness or unexpected costs, reducing strategic optionality.
Policy-driven Payer-Mix ShockA structural shift from exchange-covered to uninsured patients reduces average reimbursement and pressures volumes for elective procedures. This policy-driven payer mix change can persist across enrollment cycles, eroding margins and cash flow for multiple quarters absent policy fixes or pricing offsets.
Margin & Mix PressureCompression of margins versus prior years, driven by lower-acuity mix, surgery declines and rising professional fees, suggests profit sustainability is challenged. If mix and pro-fee inflation persist, margin recovery will be harder even with cost programs and scale.
HCA FAQ
What was Hca Healthcare’s price range in the past 12 months?
Hca Healthcare lowest stock price was $339.82 and its highest was $556.52 in the past 12 months.
What is Hca Healthcare’s market cap?
Hca Healthcare’s market cap is $84.78B.
When is Hca Healthcare’s upcoming earnings report date?
Hca Healthcare’s upcoming earnings report date is Oct 23, 2026 which is in 86 days.
How were Hca Healthcare’s earnings last quarter?
Hca Healthcare released its earnings results on Jul 24, 2026. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.562 by $0.028.
Is Hca Healthcare overvalued?
According to Wall Street analysts Hca Healthcare’s price is currently Undervalued.
Does Hca Healthcare pay dividends?
Hca Healthcare pays a Quarterly dividend of $0.78 which represents an annual dividend yield of 0.77%. See more information on Hca Healthcare dividends here
What is Hca Healthcare’s EPS estimate?
Hca Healthcare’s EPS estimate is 6.78.
How many shares outstanding does Hca Healthcare have?
Hca Healthcare has 221,839,800 shares outstanding.
What happened to Hca Healthcare’s price movement after its last earnings report?
Hca Healthcare reported an EPS of $7.59 in its last earnings report, beating expectations of $7.562. Following the earnings report the stock price went up 1.511%.
Which hedge fund is a major shareholder of Hca Healthcare?
Currently, no hedge funds are holding shares in HCA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HCA Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$450.17 (17.79% Upside)
$450.17 (17.79% Upside)
Blogger Sentiment
Bullish
HCA Sentiment 70%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 1.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 7.3%
Last 30 Days ▲ 7.3%
News Sentiment
Neutral
Bullish news 58%
Bearish news 42%
Bearish news 42%
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.33%
12-Months-Change
Fundamentals
Return on Equity
0.77%
Trailing 12-Months
Asset Growth
6.24%
Trailing 12-Months
Company Description
Hca Healthcare
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
HCA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: operational demand and underlying profitability showed resilience (11% EPS growth, volume increases outside the exchanges, meaningful Medicaid supplemental payments, ongoing capital deployment and share repurchases). However, a large, concentrated payer-mix shock from the expiration of enhanced premium tax credits (exchange enrollment down ~15% and near 1-for-1 migration to uninsured) created a significant adjusted EBITDA headwind (~$400M in Q2 and an estimated $1.0B–$1.2B full-year impact), contributed to lower cash flow this quarter, and pressured elective surgical volumes. Management has responded by updating guidance (now aligned with long-term adjusted EBITDA growth of 4%–6%), advancing cost resiliency programs, and preserving capital allocation priorities. Overall, positives (profitability, cost discipline, supplemental payment benefits, and network expansion) are balanced against material policy-driven revenue and payer-mix challenges.View all HCA earnings summariesHCA Revenue Breakdown
28.15% National Group
32.68% Atlantic Group
34.98% American Group
4.19% Corporate and other

HCA Stock 12 Month Forecast
Average Price Target
$450.17
▲(17.79% Upside)
Technical Analysis
Community Health
―
Encompass Health
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―









